Showing results (61-70 of 112) with videos related to

Sort By:
Pageof 12
In Vivo (Athens, Greece)|April 24, 2016
Strain Analysis in the Assessment of a Mouse Model of Cardiotoxicity due to Chemotherapy: Sample for Preclinical ResearchDomenica Rea, Carmela Coppola, Antonio Barbieri, et al.
Biomedicines|August 29, 2024
Addressing Post-Acute COVID-19 Syndrome in Cancer Patients, from Visceral Obesity and Myosteatosis to Systemic Inflammation: Implications in Cardio-Onco-MetabolismVincenzo Quagliariello, Maria Laura Canale, Irma Bisceglia, et al.
Cancers|March 14, 2026
A Silent Saboteur of Immunotherapy: Antibiotic Use and Its Impact on Immune Checkpoint Inhibitors Efficacy, a Systematic Review and Meta-Analysis of Recent StudiesGiuliana Ciappina, Enrica Toscano, Giordana Di Mauro, et al.
Trials|August 29, 2013
Combination of inositol and alpha lipoic acid in metabolic syndrome-affected women: a randomized placebo-controlled trialImmacolata Capasso, Emanuela Esposito, Nicola Maurea, et al.
Diabetology & Metabolic Syndrome|October 7, 2014
Metabolic syndrome-breast cancer link varies by intrinsic molecular subtypeImmacolata Capasso, Emanuela Esposito, Michelino de Laurentiis, et al.
Nutrients|September 19, 2018
Cardioprotective Effects of Nanoemulsions Loaded with Anti-Inflammatory Nutraceuticals against Doxorubicin-Induced CardiotoxicityVincenzo Quagliariello, Raffaele Vecchione, Carmela Coppola, et al.
Frontiers in Physiology|February 23, 2018
Ranolazine Attenuates Trastuzumab-Induced Heart Dysfunction by Modulating ROS ProductionGennaro Riccio, Salvatore Antonucci, Carmela Coppola, et al.
International Journal of Molecular Sciences|October 26, 2024
Glucagon-like Peptide 1 Receptor Agonists in Cardio-Oncology: Pathophysiology of Cardiometabolic Outcomes in Cancer PatientsVincenzo Quagliariello, Maria Laura Canale, Irma Bisceglia, et al.
Frontiers in Cardiovascular Medicine|September 26, 2022
Immune checkpoint inhibitor therapy increases systemic SDF-1, cardiac DAMPs Fibronectin-EDA, S100/Calgranulin, galectine-3, and NLRP3-MyD88-chemokine pathwaysVincenzo Quagliariello, Margherita Passariello, Annabella Di Mauro, et al.
Frontiers in Cardiovascular Medicine|February 6, 2023
Corrigendum: Immune checkpoint inhibitor therapy increases systemic SDF-1, cardiac DAMPs Fibronectin-EDA, S100/Calgranulin, galectine-3, and NLRP3-MyD88-chemokine pathwaysVincenzo Quagliariello, Margherita Passariello, Annabella Di Mauro, et al.
Pageof 12